Table of Content

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Exosome diagnostic and therapeutic Market – By Application
1.3.2 Europe Exosome diagnostic and therapeutic Market – By Product
1.3.3 Europe Exosome diagnostic and therapeutic Market – By End User
1.3.4 Europe Exosome Diagnostic and Therapeutic Market – By Country

2. Exosome Diagnostic And Therapeutic Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Exosome Diagnostic and Therapeutic Market – Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 Europe– PEST Analysis

5. Europe Exosome Diagnostic and Therapeutic Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis

6. Exosome Diagnostic and Therapeutic Market Analysis – By Application
6.1 Overview
6.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
6.3 Diagnostic
6.3.1 Overview
6.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
6.4 Therapeutic
6.4.1 Overview
6.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

7. Exosome Diagnostic and Therapeutic Market Analysis By Product
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.5 Software
7.5.1 Overview
7.5.2 Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8. Exosome Diagnostic and Therapeutic Market Analysis By End User
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
8.3 Cancer Institutes
8.3.1 Overview
8.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.5 Diagnostic Centres
8.5.1 Overview
8.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.6 Other End User
8.6.1 Overview
8.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9. Exosome Diagnostic and Therapeutic Market – Country Analysis
9.1 Europe: Exosome Diagnostic and Therapeutic Market
9.1.1 Overview
9.1.2 Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.3 Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)
9.1.4 Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.5 Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.6 Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
9.1.7 Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.7.1 Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8 Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.9 Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.10 Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.11 France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.12 France: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.13 France: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.14 France: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.15 UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.15.1 UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.16 UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.17 UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.18 UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.19 Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.19.1 Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.20 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.21 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.22 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.23 Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.23.1 Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.24 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.25 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.26 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10. IMPACT OF COVID-19 PANDEMIC ON EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
10.1 Europe: Impact assessment of COVID-19 Pandemic

11. COMPANY PROFILES
11.1 Cell Guidance Systems
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Evomic Science LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Norgen Biotek Corp
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Miltenyi Biotec
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 RENEURON GROUP PLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ITH, Immune Therapy Holdings AB
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 EXOSOME DIAGNOSTICS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms



List of Figures


Figure 1. Exosome Diagnostic and Therapeutic Market Segmentation
Figure 2. Exosome Diagnostic and Therapeutic Segmentation, By Region
Figure 3. Europe Exosome Diagnostic and Therapeutic Market Overview
Figure 4. Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market
Figure 5. Germany Is Expected to Show Remarkable Growth during the Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Exosome diagnostic and therapeutic market impact analysis of driver and restraints
Figure 8. Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
Figure 9. Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 10. Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 11. Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)
Figure 12. Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 15. Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)
Figure 16. Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 19. Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Europe: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)
Figure 21. Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
Figure 22. Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 23. France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 24. UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 25. Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. IMPACT OF COVID-19 PANDEMIC IN EUROPE COUNTRY MARKETS

 

List of Tables


Table 1. Europe Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)
Table 2. Europe Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 3. Europe Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 4. Germany Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 5. Germany Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 6. Germany Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 7. France Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 8. France Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 9. France Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 10. UK Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 11. UK Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 12. UK Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Italy Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 14. Italy Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Italy Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Spain Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 17. Spain Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 18. Spain Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 19. Glossary of Terms, Exosome diagnostic and treatment market